scholarly journals Nanobot: Artificial Intelligence, Drug Delivery and Diagnostic Approach

2021 ◽  
pp. 189-206
Author(s):  
Gupta Jitendra ◽  
Gupta Reena ◽  
Tankara Abhishek
Keyword(s):  
Drug Delivery ◽  
Cancer Diagnosis ◽  
Target Identification ◽  
Integrated System ◽  
Nanoelectromechanical Systems ◽  
Congenital Disease ◽  
Biologically Inspired ◽  
Synthesis Mechanism ◽  
Medication Delivery ◽  
Design Construction

The design, construction, and programming of robots with overall dimensions of less than a few micrometres, as well as the programmable assembly of nanoscale items, are all part of nanorobotics. Nanobots are the next generation of medication delivery systems, as well as the ultimate nanoelectromechanical systems. Nano bioelectronics are used as the foundation for manufacturing integrated system devices with embedded nano biosensors and actuators in the nanorobot architectural paradigm, which aids in medical target identification and drug delivery. Nanotechnology advances have made it possible to create nanosensors and actuators using nano bioelectronics and biologically inspired devices. The creation of nanobots is fascinated by both top-down and bottom-up approaches. The qualities, method of synthesis, mechanism of action, element, and application of nanobots for the treatment of nervine disorders, wound healing, cancer diagnosis study, and congenital disease were highlighted in this review. This method gives you a lot of control over the situation and helps with sickness diagnosis.

scholarly journals Review on nanoparticles used in drug delivery for cancer

2021 ◽  
Vol 16 (1) ◽  
pp. 062-069
Author(s):  
Sonam B Bisen
Keyword(s):  
Drug Delivery ◽  
Surface Properties ◽  
Cancer Diagnosis ◽  
Surgical Intervention ◽  
Optimum Size ◽  
Cancer Treatments ◽  
Medication Delivery ◽  
The Many ◽  
Cancer Diagnosis And Therapy ◽  
Drug Leakage

Current cancer treatments include surgical intervention, radiation, and chemotherapy medications. Nanoparticles have a variety of advantages as medication delivery systems. Nanoparticles (NPs) are newly discovered methods for delivering medicines to tumour cells with little drug leakage into healthy cells. To enhance biodistribution and increase circulation duration in the bloodstream, nanoparticles have been developed with optimum size and surface properties. Here, I look at the many types and features of nanoparticles. Examples of commercially available nanocarrier-based medicines include: Therapeutic nanoparticles, the function of metal nanoparticles in cancer diagnosis and therapy, are important ideas in nanoparticle medication delivery for cancer.

Strategies for Conjugation of Biomolecules to Nanoparticles as Tumor Targeting Agents

2019 ◽  
Vol 25 (37) ◽  
pp. 3917-3926
Author(s):  
Sajjad Molavipordanjani ◽  
Seyed Jalal Hosseinimehr
Keyword(s):  
Drug Delivery ◽  
Iron Oxide ◽  
Medical Imaging ◽  
Cancer Diagnosis ◽  
Carbon Nanoparticles ◽  
Tumor Targeting ◽  
Polymeric Nanoparticles ◽  
Inorganic Nanoparticles ◽  
Active Targeting ◽  
Cancer Diagnosis And Therapy

Combination of nanotechnology, biochemistry, chemistry and biotechnology provides the opportunity to design unique nanoparticles for tumor targeting, drug delivery, medical imaging and biosensing. Nanoparticles conjugated with biomolecules such as antibodies, peptides, vitamins and aptamer can resolve current challenges including low accumulation, internalization and retention at the target site in cancer diagnosis and therapy through active targeting. In this review, we focus on different strategies for conjugation of biomolecules to nanoparticles such as inorganic nanoparticles (iron oxide, gold, silica and carbon nanoparticles), liposomes, lipid and polymeric nanoparticles and their application in tumor targeting.

Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications

2020 ◽  
Vol 20 (4) ◽  
pp. 271-287 ◽  
Author(s):  
Kuldeep Rajpoot
Keyword(s):  
Drug Delivery ◽  
Cancer Therapy ◽  
Adverse Effects ◽  
Targeted Drug Delivery ◽  
Tumor Therapy ◽  
Cancer Therapies ◽  
Medication Delivery ◽  
Lipid Nanocarriers ◽  
Targeted Drug ◽  
Drug Nanocarriers

Though modern available cancer therapies are effective, they possess major adverse effects, causing non-compliance to patients. Furthermore, the majority of the polymeric-based medication platforms are certainly not universally acceptable, due to their several restrictions. With this juxtaposition, lipid-based medication delivery systems have appeared as promising drug nanocarriers to replace the majority of the polymer-based products because they are in a position to reverse polymer as well as, drug-associated restrictions. Furthermore, the amalgamation of the basic principle of nanotechnology in designing lipid nanocarriers, which are the latest form of lipid carriers, has tremendous chemotherapeutic possibilities as tumor-targeted drug-delivery pertaining to tumor therapy. Apart from this, it is reported that nearly 40% of the modern medication entities are lipophilic. Moreover, research continues to be efficient in attaining a significant understanding of the absorption and bioavailability of the developed lipids systems.

Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis

2020 ◽  
Vol 20 (11) ◽  
pp. 1288-1299
Author(s):  
Paromita Kundu ◽  
Deepika Singh ◽  
Abhalaxmi Singh ◽  
Sanjeeb K. Sahoo
Keyword(s):  
Drug Delivery ◽  
Side Effects ◽  
Cancer Diagnosis ◽  
Specific Drug ◽  
Novel Therapies ◽  
Future Directions ◽  
Normal Tissues ◽  
Cancer Management ◽  
Single Probe ◽  
Therapy And Diagnosis

The panorama of cancer treatment has taken a considerable leap over the last decade with the advancement in the upcoming novel therapies combined with modern diagnostics. Nanotheranostics is an emerging science that holds tremendous potential as a contrivance by integrating therapy and imaging in a single probe for cancer diagnosis and treatment thus offering the advantage like tumor-specific drug delivery and at the same time reduced side effects to normal tissues. The recent surge in nanomedicine research has also paved the way for multimodal theranostic nanoprobe towards personalized therapy through interaction with a specific biological system. This review presents an overview of the nano theranostics approach in cancer management and a series of different nanomaterials used in theranostics and the possible challenges with future directions.

Multifunctional quantum dot–polypeptide hybrid nanogel for targeted imaging and drug delivery

Nanoscale ◽  
2014 ◽  
Vol 6 (19) ◽  
pp. 11282-11292 ◽  
Author(s):  
Jie Yang ◽  
Ming-Hao Yao ◽  
Lang Wen ◽  
Ji-Tao Song ◽  
Ming-Zhen Zhang ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Quantum Dot ◽  
Cancer Diagnosis ◽  
Targeted Imaging ◽  
New Class

A new class of multifunctional quantum dot (QD)–polypeptide hybrid nanogel with targeted imaging and drug delivery properties is reported as a nanocarrier for use in cancer diagnosis, imaging, and therapy.

scholarly journals Comparison of Salbutamol Delivery Efficiency for Jet versus Mesh Nebulizer Using Mice

Pharmaceutics ◽  
2019 ◽  
Vol 11 (4) ◽  
pp. 192 ◽  
Author(s):  
Chang ◽  
Moon ◽  
Oh ◽  
Yoon ◽  
Gu ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Aerosol Particles ◽  
Clinical Validation ◽  
Output Rate ◽  
Medication Delivery ◽  
Jet Nebulizer ◽  
Jet Nebulizers ◽  
Effective Medication ◽  
Delivery Efficiency ◽  
Better Than

Recent reports using a breathing simulator system have suggested that mesh nebulizers provide more effective medication delivery than jet nebulizers. In this study, the performances of jet and mesh nebulizers were evaluated by comparing their aerosol drug delivery efficiencies in mice. We compared four home nebulizers: two jet nebulizers (PARI BOY SX with red and blue nozzles), a static mesh nebulizer (NE-U22), and a vibrating mesh nebulizer (NE-SM1). After mice were exposed to salbutamol aerosol, the levels of salbutamol in serum and lung were estimated by ELISA. The residual volume of salbutamol was the largest at 34.6% in PARI BOY SX, while the values for NE-U22 and NE-SM1 mesh nebulizers were each less than 1%. The salbutamol delivery efficiencies of NE-U22 and NE-SM1 were higher than that of PARI BOY SX, as the total delivered amounts of lung and serum were 39.9% and 141.7% as compared to PARI BOY SX, respectively. The delivery efficiency of the mesh nebulizer was better than that of the jet nebulizer. Although the jet nebulizer can generate smaller aerosol particles than the mesh nebulizer used in this study, the output rate of the jet nebulizer is low, resulting in lower salbutamol delivery efficiency. Therefore, clinical validation of the drug delivery efficiency according to nebulizer type is necessary to avoid overdose and reduced drug wastage.

Review on Nanotechnology and its utilization in Pharmaceuticals

2021 ◽  
pp. 319-322
Author(s):  
Kiran Patole ◽  
Anil Danane ◽  
Amit Nikam ◽  
Anuja Patil
Keyword(s):  
Drug Delivery ◽  
Pharmaceutical Industry ◽  
Molecular Biology ◽  
Drug Delivery Systems ◽  
Delivery Systems ◽  
Medication Delivery ◽  
Traditional Drug ◽  
Pharmaceutical Nanotechnology

Nanotechnology is the study of tiny structures ranging in size from 0.1 to 100 nanometers. It includes biophysics, molecular biology, and bioengineering, as well as medical subspecialties such as cardiology, ophthalmology, endocrinology, oncology, and immunology. Pharmaceutical Nanotechnology combines the methods and ideas of nanoscience and nanomedicine with pharmacy to create novel medication delivery systems that transcend the limitations of traditional drug delivery systems. The purpose of this article is to provide an overview of nanotechnology and its uses in the pharmaceutical industry.

Application of Nanomaterials in Cancer Diagnosis, Drug Delivery, and Therapy

2020 ◽  
pp. 147-171
Author(s):  
Shahid S. Siddiqui ◽  
Mashael Saeed Al-Qahtani ◽  
Faisal Ahmed Khalil Al Allaf ◽  
Loganathan Sivakumar ◽  
Zeba Kidwai Siddiqui
Keyword(s):  
Drug Delivery ◽  
Cancer Diagnosis

Current Therapies and Future Prospects

2021 ◽  
pp. 306-318
Author(s):  
Muddukrishnaiah K.
Keyword(s):  
Drug Delivery ◽  
Drug Resistance ◽  
Cancer Therapy ◽  
Cancer Diagnosis ◽  
Biomarker Discovery ◽  
Future Prospects ◽  
Cancer Treatments ◽  
Therapeutic Uses ◽  
Current Therapies ◽  
Targeted Drug

Due to drug resistance, lack of cancer cell selectivity, and solubility, conventional cancer treatments lose their therapeutic uses, and as such, new therapeutic agents need to be developed. Nanomaterials and peptides are increasingly being used in the fields of cancer diagnosis, biomarker discovery due to their therapeutic values and novel way of targeting and curing the disease. Synergism among the peptide-conjugated nanoparticles is an exhilarating group of materials, not only sharing the benefits of conventional nanomedicine, but also possessing the unique properties of excellent biocompatibility, biodegradability, versatile sensitivity, specific biological purpose, and synthetic feasibility. These virtues inspired by the scientists and have taken advantage in the peptide-conjugated nano drugs for the accurate delivery of drugs reliably to the site of the lesion. This chapter offers a summary of emerging technologies that have recently been developed in the broad field of peptide-conjugated nanoparticles and offers guidance for targeted drug delivery and cancer therapy.

Sign in / Sign up

Export Citation Format

Share Document